[28ISP-26] Development of liposome cancer drug FF-10832 (PEGylated Gemcitabine liposome) and FF-10850 (PEGylated Toptecan liposome), application of the CMC technologies for liposome CDMO services
Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.